New polyoxypregnane ester derivatives from Leptadenia hastata

Area of Science:

• Natural Product Chemistry
• Phytochemistry
• Pharmacology

Background:

• Leptadenia hastata is a plant known for its diverse chemical constituents.
• Previous studies identified less polar polyoxypregnane esters and esterified glycosides.
• Further investigation of more polar extracts is warranted to uncover novel compounds.

Purpose of the Study:

• To isolate and characterize new polyoxypregnane esters and glycosides from the polar extracts of Leptadenia hastata.
• To elucidate the structures of these novel compounds using spectral data.
• To evaluate the antitumor activity of glycosides with complex oligosaccharide chains against Raji cells.

Main Methods:

• Extraction of polar components from Leptadenia hastata.
• Isolation of 34 new congeners using chromatographic techniques.
• Structure elucidation via comprehensive spectral analysis (e.g., NMR, MS).
• In vitro antitumor activity testing on Raji cells.

Main Results:

• Thirty-four new polyoxypregnane esters and glycosides were successfully isolated.
• The isolated compounds feature sarcostin or deacetylmetaplexigenin aglycons with various ester moieties (acetyl, benzoyl, cinnamoyl, nicotinoyl, m-hydroxybenzoyl) at C-12 and/or C-20.
• The oligosaccharide chains at C-3 consist of 2,6-dideoxy-3-O-methylpyranoses, 6-deoxy-3-O-methylpyranoses, or glucose, varying in length (three to five units).
• Preliminary antitumor activity was observed in glycosides with more complex oligosaccharidic structures.

Conclusions:

• The polar extracts of Leptadenia hastata are a rich source of structurally diverse polyoxypregnane derivatives.
• The elucidated structures provide valuable insights into the chemical variability of this plant genus.
• Further research into the antitumor potential of these novel glycosides is justified.